8-K

Company

ADMA BIOLOGICS, INC.

Filed

January 2, 2025

Period of Report

December 30, 2024

Accession Number

0001140361-25-000073

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →